The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration

MLA

Theodoros Tsakiridis, et al. “The Diabetes Medication Canagliflozin Reduces Cancer Cell Proliferation by Inhibiting Mitochondrial Complex-I Supported Respiration.” Molecular Metabolism, vol. 5, no. 10, Oct. 2016, pp. 1048–56. EBSCOhost, https://doi.org/10.1016/j.molmet.2016.08.014.

APA

Theodoros Tsakiridis, Brennan K. Smith, Katarina Marcinko, Linda Villani, Alex E. Green, Lindsay A. Broadfield, Vanessa P. Houde, Paola Muti, Rebecca J. Ford, & Gregory R. Steinberg. (2016). The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration. Molecular Metabolism, 5(10), 1048–1056. https://doi.org/10.1016/j.molmet.2016.08.014

Chicago

Theodoros Tsakiridis, Brennan K. Smith, Katarina Marcinko, Linda Villani, Alex E. Green, Lindsay A. Broadfield, Vanessa P. Houde, Paola Muti, Rebecca J. Ford, and Gregory R. Steinberg. 2016. “The Diabetes Medication Canagliflozin Reduces Cancer Cell Proliferation by Inhibiting Mitochondrial Complex-I Supported Respiration.” Molecular Metabolism 5 (10): 1048–56. doi:10.1016/j.molmet.2016.08.014.